pamidronate has been researched along with Experimental Mammary Neoplasms in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Bone cancer was induced by intra-tibial injections of murine mammary carcinoma cells (4T1) in immunocompetent BALB/c mice and treated intraperitoneally for up to 5 weeks with vehicle, rapamycin or pamidronate (a bisphosphonate currently used to reduce bone loss in bone cancer patients)." | 3.80 | Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin. ( Abdelaziz, DM; Komarova, SV; Stone, LS, 2014) |
| " In the present study we have evaluated the therapeutic efficacy of pamidronate (3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid) combined with mitomycin C (MMC) on bone metastasis of breast cancer using an animal model." | 1.29 | Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. ( Enomoto, K; Ikeda, T; Ishii, S; Kitajima, M; Tamura, H; Wada, N, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelaziz, DM | 1 |
| Stone, LS | 1 |
| Komarova, SV | 1 |
| Tamura, H | 1 |
| Ishii, S | 1 |
| Ikeda, T | 1 |
| Wada, N | 1 |
| Enomoto, K | 1 |
| Kitajima, M | 1 |
| Diel, IJ | 1 |
| Wingen, F | 1 |
| Pool, BL | 1 |
| Klein, P | 1 |
| Klenner, T | 1 |
| Schmähl, D | 1 |
1 review available for pamidronate and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[Bisphosphonates in the adjuvant therapy of breast cancer-- pathophysiology, animal models, and clinical experiences].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Neoplasms; | 1998 |
1 trial available for pamidronate and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[Bisphosphonates in the adjuvant therapy of breast cancer-- pathophysiology, animal models, and clinical experiences].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Neoplasms; | 1998 |
3 other studies available for pamidronate and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin.
Topics: Animals; Antibiotics, Antineoplastic; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, T | 2014 |
Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Diphosphonates; | 1996 |
Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat--benefit of combining bisphosphonates with cytostatic agents.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Female; Mammary Neoplasms, | 1988 |